Amilcar Tanuri

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biologia

Departamento:

Departamento de Genética/IB

ORCID:

não disponível no Lattes


Formação:
  • Center For Disease Control

    | Pós-Doutorado | 1996 - 1998
  • University of Sussex

    genetica molecular | Especialização | 1985 - 1985
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Genética) | Doutorado | 1985 - 1990
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Mestrado | 1982 - 1985
  • Universidade Federal do Rio de Janeiro

    medicina | Graduação | 1977 - 1982
Laboratórios:
Nuvens de Palavras:
Artigos:

(79.50% artigos com DOI)

Titulo DOI Ano
Cost-effective 3D lung tissue spheroid as a model for SARS-CoV -2 infection and drug screening 10.1111/aor.14729 2024
Postnatal Zika virus infection leads to morphological and cellular alterations within the neurogenic niche 10.1242/dmm.050375 2024
Mpox outbreak in Rio de Janeiro, Brazil: A translational approach 10.1002/jmv.29621 2024
HIV latency-reversing activity of latex from Euphorbia umbellata (Pax) Bruyns and three diterpenes isolated from this species 10.1080/14786419.2024.2364261 2024
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2 10.1073/pnas.2214561120 2023
Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture 10.3390/v15030801 2023
Co-circulation of vaccinia and monkeypox viruses in rural areas of Brazil: Importance of differential molecular diagnosis 10.1016/j.tmaid.2023.102578 2023
Case report: Regression of Glioblastoma after flavivirus infection 10.3389/fmed.2023.1192070 2023
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat 10.1590/0074-02760230056 2023
Cutting Edge: Polycomb Repressive Complex 1 Subunit Cbx4 Positively Regulates Effector Responses in CD8 T Cells 10.4049/jimmunol.2200757 2023
Accuracy of a raw saliva-based COVID-19 RT-LAMP diagnostic assay 10.1016/j.bjid.2023.102790 2023
Assessing the role of Ndel1 oligopeptidase activity in congenital Zika syndrome: Potential predictor of congenital syndrome endophenotype and treatment response 10.1111/jnc.15918 2023
Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions 10.3390/v15071545 2023
Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018 10.1371/journal.pntd.0011536 2023
Congenital Zika Virus Infection Impairs Corpus Callosum Development 10.3390/v15122336 2023
Lessons from a Multilaboratorial Task Force for Diagnosis of a Fatal Toxoplasmosis Outbreak in Captive Primates in Brazil 10.3390/microorganisms11122888 2023
SARS-CoV-2 egress from Vero cells: a morphological approach 10.1007/s00418-023-02239-9 2023
Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies 10.1016/j.isci.2023.107219 2023
Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation 10.1016/j.ebiom.2021.103774 2022
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests 10.1016/j.jcv.2022.105080 2022
Emergence of Within-Host SARS-CoV-2 Recombinant Genome After Coinfection by Gamma and Delta Variants: A Case Report 10.3389/fpubh.2022.849978 2022
Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens 10.1128/spectrum.01250-22 2022
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models 10.1186/s12977-022-00600-9 2022
Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil 10.1001/jama.2022.11006 2022
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines 10.1016/j.antiviral.2022.105373 2022
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants 10.1084/jem.20220367 2022
Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19 10.1590/0037-8682-0534-2021 2022
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum 10.3389/fimmu.2022.884760 2022
From a recombinant key antigen to an accurate, affordable serological test: lessons learnt from COVID-19 for future pandemics 10.1016/j.bej.2022.108537 2022
A SARS-CoV-2 Negative Antigen Rapid Diagnostic in RT-qPCR Positive Samples Correlates With a Low Likelihood of Infectious Viruses in the Nasopharynx 10.3389/fmicb.2022.912138 2022
Copper regulation disturbance linked to oxidative stress and cell death during Zika virus infection in human astrocytes 10.1002/jcb.30323 2022
Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants 10.1099/mgen.0.000859 2022
COVID-19 cross-sectional study in Maricá, Brazil: The impact of vaccination coverage on viral incidence 10.1371/journal.pone.0269011 2022
Discovery of two novel Torque Teno viruses in Callithrix penicillata provides insights on Anelloviridae diversification dynamics 10.3389/fmicb.2022.1002963 2022
Unusual epidemiological presentation of the first reports of monkeypox in a low-income region of Brazil 10.1016/j.tmaid.2022.102466 2022
10.1590/0001-3765202220211361. eCollection 2022 10.1590/0001-3765202220211361 2022
Multicenter Diagnostic Evaluation of a Novel Coronavirus Antigen Lateral Flow Test among Symptomatic Individuals in Brazil and the United Kingdom 10.1128/spectrum.02012-22 2022
SARS-CoV-2 Spatiotemporal Genomic and Molecular Analysis of the First Wave of the COVID-19 Pandemic in Macaé, the Brazilian Capital of Oil 10.3390/ijms231911497 2022
The long-term dynamics of serum antibodies against SARS-CoV-2 10.7717/peerj.14547 2022
Characterization of HIV-1 Transmission Clusters Inferred from the Brazilian Nationwide Genotyping Service Database 10.3390/v14122768 2022
Zika Virus Strains and Dengue Virus Induce Distinct Proteomic Changes in Neural Stem Cells and Neurospheres 10.1007/s12035-022-02922-3 2022
Analytical and clinical performance of molecular assay used by the Brazilian public laboratory network to detect and discriminate Zika, Dengue and Chikungunya viruses in blood 10.1016/j.bjid.2021.101542 2021
Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study 10.3389/fmed.2021.630982 2021
Intracellular host cell membrane remodelling induced by SARS-CoV-2 infection in vitro 10.1111/boc.202000146 2021
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil 10.1128/JVI.00119-21 2021
Common Dysregulation of Innate Immunity Pathways in Human Primary Astrocytes Infected With Chikungunya, Mayaro, Oropouche, and Zika Viruses 10.3389/fcimb.2021.641261 2021
Transmission dynamics and molecular characterization of HIV-1 epidemic among therapeutic failure patients in Santa Catarina state, southern Brazil 10.1016/j.meegid.2021.104854 2021
Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg 10.3389/fgene.2021.639364 2021
Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress 10.1038/s41598-021-88944-8 2021
Phorbol Esters from the Latex of : Bioguided Isolation of Highly Potent HIV-1 Latency Interrupters in Virus Reservoir Cells 10.1021/acs.jnatprod.0c01092 2021
The incidence and geographical spread of SARS-CoV-2 in Rio de Janeiro, Brazil based on RT-PCR test results 10.1590/0037-8682-0779-2020 2021
Molecular epidemiological investigation of Mayaro virus in febrile patients from Goiania City, 2017-2018 10.1016/j.meegid.2021.104981 2021
Whole-exome sequencing reveals insights into genetic susceptibility to Congenital Zika Syndrome 10.1371/journal.pntd.0009507 2021
Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells 10.1016/j.bbagen.2021.129963 2021
Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study 10.3389/fmicb.2021.690647 2021
HIV-1 molecular diversity in Brazil unveiled by 10 years of sampling by the national genotyping network 10.1038/s41598-021-94542-5 2021
COVID-19 diagnosis by RT-qPCR in alternative specimens 10.1590/0074-02760210085 2021
Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals 10.1038/s41397-021-00254-4 2021
Differential Expression of Human MicroRNAs During Dengue Virus Infection in THP-1 Monocytes 10.3389/fcimb.2021.714088 2021
A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels 10.1038/s41598-021-97330-3 2021
Molecular testing and analysis of disease spreading during the emergence of COVID-19 in Macaé, the Brazilian National Capital of Oil 10.1038/s41598-021-99475-7 2021
Performance of an alternative RT-PCR procedure using residual sample from the Panbio- Ag COVID-19 test 10.1016/j.bjid.2021.101630 2021
Turnover of SARS-CoV-2 Lineages Shaped the Pandemic and Enabled the Emergence of New Variants in the State of Rio de Janeiro, Brazil 10.3390/v13102013 2021
Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil 10.1128/jvi.01228-21 2021
Epidemiological dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil 10.1093/ve/veab087 2021
Polyclonal F(ab?)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency 10.1016/j.isci.2021.103315 2021
Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk 10.1128/spectrum.00855-21 2021
Association between Maternal Non-Coding Interferon-λ Polymorphisms and Congenital Zika Syndrome in a Cohort from Brazilian Northeast 10.3390/v13112253 2021
Identification and characterisation of SARS-CoV-2 and Human alphaherpesvirus 1 from a productive coinfection in a fatal COVID-19 case 10.1590/0074-02760210176 2021
Zika virus infection leads to mitochondrial failure, oxidative stress and DNA damage in human iPSC-derived astrocytes 10.1038/s41598-020-57914-x 2020
Congenital Zika syndrome is associated with maternal protein malnutrition 10.1126/sciadv.aaw6284 2020
The cyanobacterial saxitoxin exacerbates neural cell death and brain malformations induced by Zika virus 10.1371/journal.pntd.0008060 2020
Serology testing in the COVID-19 pandemic response 10.1016/S1473-3099(20)30517-X 2020
Evolution and epidemic spread of SARS-CoV-2 in Brazil 10.1126/science.abd2161 2020
Reactivation of latent HIV-1 via AID/APOBEC 10.1089/aid.2019.0221 2020
Correction to: Use of a NAT-based assay to improve the surveillance system and prevent transfusion-transmitted malaria in blood banks 10.1186/s12936-020-03396-1 2020
Obstetric and perinatal outcomes in cases of congenital Zika syndrome. 10.1002/pd.5831 2020
Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome 10.1126/scisignal.aay6736 2020
Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy 10.1038/s41598-020-73162-5 2020
Zika Induces Human Placental Damage and Inflammation 10.3389/fimmu.2020.02146 2020
Outcomes of subsequent pregnancies following Zika virus infection: A comparative case series 10.1002/ijgo.13288 2020
Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19 10.1590/0037-8682-0477-2020 2020
Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil 10.1590/1678-4685-gmb-2018-0237 2020
Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey 10.1016/S2352-3018(20)30252-6 2020
Laboratory Acquired Zika Virus Infection Through Mouse Bite: A Case Report 10.1093/ofid/ofaa259 2020
Maternal SARS-CoV-2 infection associated to systemic inflammatory response and pericardial effusion in the newborn: a Case-Report 10.1093/jpids/piaa133 2020
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo 10.1371/journal.pntd.0007072 2019
Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines 10.1007/s10637-019-00728-0 2019
Association between MBL2 haplotypes and dengue severity in children from Rio de Janeiro, Brazil 10.1590/0074-02760190004 2019
MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection 10.1177/1759091419850983 2019
Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country? 10.1186/s12981-019-0234-2 2019
Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation 10.1016/s1473-3099(19)30293-2 2019
Development and validation of a simple and rapid way to generate low volume of plasma to be used in point-of-care HIV virus load technologies 10.1016/j.bjid.2019.10.010 2019
The performance of a new point-of-care HIV virus load technology to identify patients failing antiretroviral treatment 10.1016/j.jcv.2019.104212 2019
The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors 10.1111/trf.14478 2018
Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals 10.1002/jia2.25032 2018
Dr. Roimicher, , reply 10.3899/jrheum.171089 2018
Occurrence of Harmful Cyanobacteria in Drinking Water from a Severely Drought-Impacted Semi-arid Region 10.3389/fmicb.2018.00176 2018
MicroRNA and cellular targets profiling reveal miR-217 and miR-576-3p as proviral factors during Oropouche infection 10.1371/journal.pntd.0006508 2018
Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene 10.1590/1678-4685-gmb-2017-0065 2018
Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individuals 10.1093/jac/dky190 2018
Zika virus impairs the development of blood vessels in a mouse model of congenital infection 10.1038/s41598-018-31149-3 2018
Genomic and epidemiological monitoring of yellow fever virus transmission potential 10.1126/science.aat7115 2018
Pregnant women co-infected with HIV and Zika: Outcomes and birth defects in infants according to maternal symptomatology 10.1371/journal.pone.0200168 2018
Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope 10.1038/s41598-018-27855-7 2018
Variations in maternal adenylate cyclase genes are associated with congenital Zika syndrome in a cohort from Northeast, Brazil 10.1111/joim.12829 2018
One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil 10.1016/j.bjid.2018.08.003 2018
Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection 10.3389/fmed.2018.00025 2018
Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex 10.1371/journal.pone.0207664 2018
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis 10.1016/S1473-3099(18)30647-9 2018
Zika Virus causing encephalomyelitis associated with immunoactivation. 10.1093/ofid/ofw203 2017
Pregnant women carrying microcephaly foetuses and Zika virus contain potentially pathogenic microbes and parasites in their amniotic fluid 10.1186/s12920-016-0242-1 2017
HTLV-1 Tax activates HIV-1 transcription in latency models 10.1016/j.virol.2017.01.014 2017
Dengue infection in the nervous system: lessons learned for Zika and Chikungunya 10.1590/0004-282x20160189 2017
Congenital Zika Virus Infection 10.1001/jamaneurol.2017.0051 2017
The spectrum of neuropathological changes associated with congenital Zika virus infection 10.1007/s00401-017-1699-5 2017
Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas 10.1093/jac/dkx025 2017
Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review 10.1590/0074-02760160510 2017
First report of persistent dengue-1-associated autoimmune neurological disturbance: neuromyelitis optica spectrum disorder 10.1007/s13365-017-0555-7 2017
Zika Virus in the Joint of a Patient with Rheumatoid Arthritis 10.3899/jrheum.160722 2017
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae 10.1038/s41598-017-09797-8 2017
A3-Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo, Mozambique 10.1093/ve/vew036.002 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis 10.1016/S1473-3099(17)30702-8 2017
Zika Virus Infects, Activates, and Crosses Brain Microvascular Endothelial Cells, without Barrier Disruption 10.3389/fmicb.2017.02557 2017
Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study 10.1016/s1473-3099(16)00095-5 2016
Zika virus impairs growth in human neurospheres and brain organoids 10.1126/science.aaf6116 2016
Forging Collaborative Relationships in Brazil: From AIDS to ZIKV 10.1016/j.cell.2016.06.023 2016
Association between KIR genotypes and HLA-B alleles on viral load in Southern Brazilian individuals infected by HIV-1 subtypes B and C 10.1016/j.humimm.2016.06.013 2016
Evidence for Transmission of Zika Virus by Platelet Transfusion 10.1056/NEJMc1607262 2016
Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can Expect to See Prenatally and Postnatally 10.1148/radiol.2016161584 2016
Development of a rapid phenotypic test for HCV protease inhibitors with potential use in clinical decisions 10.1590/1678-4685-GMB-2016-0022 2016
Congenital Zika Virus Infection 10.1001/jamaneurol.2016.3720 2016
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives 10.1186/s12967-016-1047-x 2016
Development of a qualitative qPCR test to identify patients failing first time therapy to NNRTI 10.1089/AID.2016.0152 2016
Carpal tunnel syndrome after chikungunya infection 10.1016/j.ijid.2016.10.019 2016
Immune activation in amniotic fluid from zika virus associated microcephaly 10.1002/ana.24839 2016
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models 10.3390/v8120322 2016
Identification of novel resistance-related polymorphisms in HIV-1 subtype C RT connection and RNase H domains from patients under virological failure in Brazil 10.1089/aid.2015.0376 2016
Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection 10.1007/s13365-015-0328-0 2015
Follow-up on long-term antiretroviral therapy for cats infected with feline immunodeficiency virus 10.1177/1098612x15580144 2015
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis 10.1371/journal.pmed.1001810 2015
Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique 10.1371/journal.pone.0130580 2015
Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity 10.3390/molecules200611474 2015
Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR 10.1371/journal.pone.0097257 2014
Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling 10.1097/QAD.0000000000000289 2014
HIV-1 Nef Inhibits Protease Activity and Its Absence Alters Protein Content of Mature Viral Particles 10.1371/journal.pone.0095352 2014
Use of the heteroduplex mobility assay and cell sorting to select genome sequences of the CCR5 gene in HEK 293T cells edited by transcription activator-like effector nucleases 10.1590/s1415-47572014000100018 2014
Genetic Diversity in HIV-1 Subtype C LTR from Brazil and Mozambique Generates New Transcription Factor-Binding Sites 10.3390/v6062495 2014
Reactivation of latent HIV-1 by new semi-synthetic ingenol esters 10.1016/j.virol.2014.05.033 2014
2´,3´-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication 10.2174/1570162x12666140826105824 2014
Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study 10.1186/1743-422X-10-57 2013
Synthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue Virus Replication 10.1371/journal.pone.0082504 2013
Genetic Analysis and Natural Polymorphisms in HIV-1 gp41 isolates from Maputo city, Mozambique 10.1089/aid.2013.0244 2013
Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique 10.1371/journal.pone.0068213 2013
Vaccine research, development, and innovation in Brazil: A translational science perspective 10.1016/j.vaccine.2012.11.084 2013
Field expansion of DNA polymerase chain reaction for early infant diagnosis of HIV-1: The Ethiopian experience 10.4102/ajlm.v2i1.31 2013
Genetic Diversity and Naturally Polymorphisms in HIV Type 1 Integrase Isolates from Maputo, Mozambique: Implications for Integrase Inhibitors 10.1089/aid.2012.0058 2012
In vitro Reduced Susceptibility to Artemether in P. falciparum and its Association with Polymorphisms on Transporter Genes 10.1093/infdis/jis359 2012
Natural transmission of feline immunodeficiency virus from infected queen to kitten 10.1186/1743-422X-9-99 2012
Emergence of Dengue virus 4 genotypes II b and I in the city of Rio de Janeiro 10.1016/j.jcv.2012.10.006 2012
Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C 10.1371/journal.pone.0046622 2012
Accumulation of P(T/S)AP Late Domain Duplications in HIV Type 1 Subtypes B, C, and F Derived from Individuals Failing ARV Therapy and ARV Drug-Naive Patients 10.1089/aid.2010.0282 2011
Enhanced Th17 Phenotype in Uninfected Neonates Born from Viremic HIV-1-Infected Pregnant Women 10.1007/s10875-010-9485-3 2011
Global trends in molecular epidemiology of HIV-1 during 2000¿2007 10.1097/QAD.0b013e328342ff93 2011
Genetic Characterization of Human T-Cell Lymphotropic Virus Type 1 in Mozambique: Transcontinental Lineages Drive the HTLV-1 Endemic 10.1371/journal.pntd.0001038 2011
Frequency of Human Immunodeficiency Virus Type-2 in HIV Infected Patients in Maputo City, Mozambique 10.1186/1743-422X-8-408 2011
Genotypic Analysis of the gp41 HR1 Region From HIV-1 isolates From Enfuvirtide-Treated and Untreated Patients 10.1097/QAI.0b013e31821e9d29 2011
Prevalence of Etravirine-Associated Mutations in Clinical Samples With Genotypic Resistance to Nevirapine and Efavirenz in Brazilian Clinics 10.1097/QAI.0b013e31821e9cf6 2011
Two Lineages of Dengue Virus Type 2, Brazil 10.3201/eid1603.090996 2010
Failure of Highly Active Antiretroviral Therapy in Reconstituting Immune Response to Clostridium tetani Vaccine in Aged AIDS Patients 10.1097/QAI.0b013e3181d6003b 2010
Frequency of Primary Resistance to Antiretroviral Drugs and Genetic Variability of HIV-1 Among Infected Pregnant Women Recently Diagnosed in Luanda-Angola 10.1089/aid.2010.0111 2010
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure? 10.1016/j.meegid.2008.10.002 2009
IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment 10.1097/QAD.0b013e328317461e 2009
Enfuvirtide (T-20) Resistance-Related Mutations in HIV Type 1 Subtypes B, C, and F Isolates from Brazilian Patients Failing HAART 10.1089/aid.2008.0160 2009
Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique 10.1111/j.1537-2995.2009.02100.x 2009
Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV 10.1186/1758-2652-12-20 2009
Developing Laboratory Systems and Infrastructure for HIV Scale-Up: A Tool for Health Systems Strengthening in Resource-Limited Settings 10.1097/QAI.0b013e3181bbc9f5 2009
Interactions between SIVNef, SIVGagPol and Alix correlate with viral replication and progression to AIDS in rhesus macaques 10.1016/j.virol.2009.08.024 2009
Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage 10.1093/jac/dkp315 2009
Co-infection by human immunodeficiency virus type 1 (HIV-1) subtype C and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? 10.1186/1471-2334-9-211 2009
Hepatitis C virus incident cases open the possibility to study transmission route and source of infection 10.1111/j.1537-2995.2009.02167.x 2009
The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme. 10.1016/j.antiviral.2007.08.006 2008
Early Diagnosis of Human Immunodeficiency Virus in Infants Using Polymerase Chain Reaction on Dried Blood Spots in Botswana?s National Program for Prevention of Mother-to-Child Transmission 10.1097/INF.0b013e3181469050 2008
Altered immunological reactivity in HIV-1-exposed uninfected neonates 10.1016/j.clim.2008.01.020 2008
Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. 10.1093/jac/dkn099 2008
The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase 2008
World Health Organization/HIVResNet Drug Resistance Laboratory Strategy 2008
Phylogenetic and Genetic Analysis of Feline Immunodeficiency Virus gag, pol, and env Genes from Domestic Cats Undergoing Nucleoside Reverse Transcriptase Inhibitor Treatment or Treatment-Naive Cats in Rio de Janeiro, Brazil 10.1128/JVI.00310-08 2008
False I50V resistance readings of HIV isolates: co-amplification of NASBA HIV-1 RNA QT internal calibrators and HIV-1 patient isolates may lead to a false I50V mutation resistance reading in genotypic tests 10.1007/s00705-008-0138-2 2008
Bayesian network analyses of resistance pathways against efavirenz and nevirapine 10.1097/QAD.0b013e32830fe940 2008
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique 10.1007/s00705-008-0215-6 2008
Drug Resistance Mutation Profile and Accumulation Kinetics in Human Immunodeficiency Virus-Positive Individuals Infected with Subtypes B and F Failing Highly Active Antiretroviral Therapy Are Influenced by Different Viral Codon Usage Patterns 10.1128/AAC.00820-08 2008
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. 10.1016/j.meegid.2006.09.004 2007
Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification. 10.1128/AAC.00749-06 2007
Serodiagnosis of equine infectious anemia by agar gel immunodiffusion and ELISA using a recombinant p26 viral protein expressed in Escherichia coli as antigen 10.1016/j.prevetmed.2006.10.009 2007
Differential drug resistance acquisition in HIV-1 of subtypes B and C. 10.1371/journal.pone.0000730 2007
Production of the HIV-Suppressive Chemokines CCL3/MIP-1? and CCL22/MDC Is Associated with More Effective Antiretroviral Therapy in HIV-Infected Children 10.1097/INF.0b013e31812714db 2007
Vpr.A3A Chimera Inhibits HIV Replication 10.1074/jbc.M706436200 2007
Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors 10.1111/j.1537-2995.2007.01069.x 2007
Evaluation and Implementation of Rapid HIV Tests: The Experience in 11 African Countries 10.1089/aid.2007.0020 2007
Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor ?? production 10.1097/QAD.0b013e3282ca83fa 2007
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. 10.1128/AAC.50.2.694-701.2006 2006
Determinants of HIV-1 mother-to-child transmission in Southern Brazil. 10.1590/S0001-37652006000100011 2006
Biological characterization of HIV-1 subtype C protease carrying indinavir drug resistance mutations. 10.1099/vir.0.81517-0 2006
DBCollHIV: a database system for collaborative HIV analysis in Brazil. 2006
Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. 10.1186/1742-4690-3-33 2006
GAG-POL bearing a reverse transcriptase drug-resistant mutation influences viral genomic RNA incorporation into human immunodeficiency virus type-1 particles 10.1099/vir.0.82046-0 2006
Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. 10.1097/01.aids.0000247573.95880.db 2006
Molecular dynamics analysis of HIV-1 matrix protein: Clarifying differences between crystallographic and solution structures 10.1016/j.jmgm.2006.09.009 2006
CCR5 chemokine receptor gene evolution in New World monkeys (Platyrrhini, Primates): implication on resistance to lentiviruses 10.1016/j.meegid.2004.07.009 2005
Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration. 10.1371/journal.pmed.0020112 2005
Low accumulation of L90M in the Human Immunodeficiency Virus type 1 (HIV-1) protease from subtype F failing protease inhibitors is caused by L89M polymorphism. 10.1086/430002 2005
Different epidemic potentials of the HIV-1B and C subtypes 10.1007/s00239-004-0206-5 2005
HIV-1 subtype C dissemination in southern Brazil. AIDS. 00002030-200510004-00014 2005
Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. 10.1128/JCM.42.1.426?430.2004 2004
Genotypic Resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. 2004
Synonymous Genetic Polymorphisms within Brazilian Human Immunodeficiency Virus Type 1 Subtypes May Influence Mutational Routes to Drug Resistance 2004
Primary HIV-1 drug resistance in Brazil 10.1097/01.aids.0000131317.90644.c9 2004
Impact of Nelfinavir Resistance Mutations on In Vitro Phenotype,Fitness, and Replication Capacity of Human ImmunodeficiencyVirus Type 1 with Subtype B and C Proteases 10.1128/AAC.48.9.3552?3555.2004 2004
Crystallization of a non-B and a B mutant HIV protease 2004
Alternative, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. 2004
Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil. 2004
Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF 2004
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil 10.1097/01.aids.0000042595.93174.a4 2003
Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals 10.1097/01.aids.0000060345.12269.d7 2003
In Vitro Hypersusceptibility of Human Immunodeficiency Virus Type 1Subtype C Protease to Lopinavir 10.1128/AAC.47.9.2817?2822.2003 2003
Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy. 2003
Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. 2003
Synthesis and anti-HIV activity of new C(2) symmetric derivatives designed as HIV-1 protease inhibitors. 2003
Brazilian Network for Drug Resistance Surveillance.A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. 2003
Sexual transmission of HIV-1 isolate showing G-->A hypermutation. 2002
Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART 2002
Prevalence of Protease and Reverse Transcriptase Drug Resistance Mutations over Time in Drug-Naive Human Immunodeficiency Virus Type 1-Positive Individuals in Rio de Janeiro, Brazil. 2002
Genotypic and Phenotypic Resistance Testing in B and non-B Human Immunodeficiency Virus type 1 (HIV-1) Isolates from Children Failing Antiretroviral Therapy. 2002
Testing Genotypic and Phenotypic Resistance in Human Immunodeficiency Virus Type 1 Isolates of Clade B and Other Clades from Children Failing Antiretroviral Therapy 10.1128/JCM.40.12.4512?4519.2002 2002
High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions. 2002
Genetic Variability of HIV-1 Protease from Nigeria and Correlation with Protease Inhibitors Drug Resistance 2001
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. 2001
The AIDS epidemic in the Amazon Basin, is driven by prototypic and recombinant HIV-1 subtypes B and F 2000
Generation of Intersubtype Human Immunodeficiency Virus Type 1 Recombinants in env Gene In Vitro: Influences in the Biological Behavior and in the Establishment of Productive Infections 10.1006/viro.1999.0133 2000
HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization 2000
Evidence for a high frequency of subtype F infections among heterosexual population in Buenos Aries City, Argentina 2000
Protease sequences from HIV group M subtypes A-H revealed distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individual worldwide 2000
Drug-resistant Reverse Transcriptase Genotyping and Phenotyping of B and non-B Subtypes (F and A) of Human Immunodeficiency Virus Type I Found in Brazilian Patients Failing HAART 10.1006/viro.2000.0487 2000
Construction of a Selectable nef-Defective Live-Attenuated Human Immunodeficiency Virus Expressing Escherichia coli gpt Gene 10.1006/viro.1999.0145 2000
Hiv-1 Subtypes Among Blood Donors From Rio de Janeiro, Brazil 1999
Genetic Variation and Susceptibilities to Protease Inhibitors among Subtype B and F Isolates in Brazil 1999
Dual And Recombinant Infections: An Integral Part Of The Hiv-1 Epidemic In Brazil. 1999
Predominance Of Human Immunodeficiency Virus Type 2 Subtype B In Abidjan, Ivory Coast 1999
Sequence diversity of reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals 1999
HIV-1 subtyping in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics. 1999
Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. 1999
Horizontal And Vertical Transmission Of Human Immunodeficiency Virus Type 1 Dual Infections Caused By Viruses If Subtypes B And C 1998
Use Of T7 Gene 6 Exonuclease And Phosphothioated Primers For The Manipulation Of Hiv-1 Infectious Clones. 1998
Differences In The Prevalence Of Hiv-1 Subtypes In Male And Female Participants Of A Cohort Study In Rio de Janeiro, Brazil 1998
Molecular Epidemiologic Evidence For Discontinuous Introduction Of Subtype B And F Into Rio de Janeiro, Brazil. 1998
Introduction Of Hiv-2 And Multiple Hiv-1 Subtypes To Lebanon. 1998
Detection Of Genetically Diverse Human Immunodeficiency Virus Type 1 Group M And O Isolates By Pcr 1997
Tissue Culture Adaptation Of Foot-And-Mouth Disease Virus Selects Viruses That Bind To Heparin And Are Attenuated In Cattle 1997
A Nationwide Effort To Sistematicaly Monito Hiv-1 Diversity In Brazil: Preliminary Results 1996
Identification Of Single And Dual Infections With Distinci Subtypes Of Human Immunodeficiency Virus Type 1 By Using Restriction Fragmente Lenght Polymorphism Analysis 1996
Sequence And Phylogenetic Analysis If Gp120 An Hiv-1 Variant (Gwgr) Higly Prevalent In Brazil 1995
Hiv-1 Patients May Harbor Viruses Of Different Phylogenetic: Implications For The Evolution Of The Hiv/Aids Pandemic 1995
Epidemiologic And Evolutionary Relationships Between Romanian And Brazilian Hiv-1 Subtype F Strains 1995
Reversible changes in isoenzyme eletrophoretic mobility pattern infectivity for mice in clones of Trypanossoma cruzi. 1993
N-Terminal aminoacids are essential for foot-and-mouth disease virus replicase activity. 1992
In vitro activities of recombinant foot-and-mouth disease virus replicase expressed in E.coli. 1992
Site directed mutagenesis of the foot-and-mouth disease virus RNA-Polymerase. 1991
Expression of an active foot-and-mouth disease virus RNA Polymerase in E.coli. 1991
Cloning of structural genes for colicin V and their role in pathogenicity of invasive Escherichia coli. 1991
Isoenzyme Variation In Clones of T. cruzi 1990
Direct Expression Of The Foot-And-Mouth Disease Virus Rna-Polymerase In Escherichia Coli. 1990
Isolation And Characterization Of Drug-Resistant Mutants Of "Herpetomonas Samuelpessoai". 1988
Partial Purification Of Chimera B-Galactosidades Containing Determinants Of "Trypanosoma Cruzi". 1988
Ultraestrutural Aspects Of "Crithidia Guilhermei". 1987
Trypanossoma cruzi: Isolation of cloned strains and characterization of their infectivity 1985
A Simple Higerly Efficient Plating Method For Trypanosomatids. 1981
Caracterizacao de T. Cruzi Isolados Por Plaqueamento Em Meio Solido. 1981
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Horizontal and Vertical Transmission of HIV-1 Dual Infections caused by Viruses of Subtypes B and C. 1997
HIV-1 strains from Brazil May Consist of Mosaic Genome Structure 1997
Characterization Of Hiv-1 Dual Infection Of Rio de Janeiro 1996
Detection Of Hiv-1 Group M And O Virus By Pcr 1996
Differences In The Prevalence Of Hiv-1 Subtypes In Male And Female Participants Of A Cohort Study In Rio de Janeiro, Brazil 1996
Hiv-1 Infections In Brazil: Single, Duals And Recombinants 1996
Publicações:
Minha Rede: